* LeMaitre Vascular Inc LMAT.OQ reported quarterly
adjusted
earnings of 49 cents per share for the quarter ended September
30, higher than the same quarter last year, when the company
reported EPS of 33 cents. The mean expectation of ten analysts
for the quarter was for earnings of 44 cents per share. Wall
Street expected results to range from 42 cents to 45 cents per
share.
* Revenue rose 15.6% to $54.82 million from a year ago;
analysts
expected $53.50 million.
* LeMaitre Vascular Inc's reported EPS for the quarter was
49
cents.
* The company reported quarterly net income of $11.14
million.
* LeMaitre Vascular Inc shares had fallen by 4.1% this
quarter and
gained 56.9% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 0.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for LeMaitre Vascular
Inc is 100.00
This summary was machine generated from LSEG data November 1 at
03:35 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 0.44 0.49 Beat
Jun. 30 2024 0.47 0.52 Beat
Mar. 31 2024 0.39 0.44 Beat
Dec. 31 2023 0.36 0.38 Beat